Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.42)
# 933
Out of 4,944 analysts
511
Total ratings
39.44%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $60 → $64 | $34.83 | +83.75% | 5 | Aug 13, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $12 → $8 | $3.27 | +144.65% | 20 | Aug 12, 2025 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $24.02 | +33.22% | 3 | Aug 8, 2025 | |
| LFMD LifeMD | Maintains: Buy | $14 → $13 | $6.83 | +90.34% | 10 | Aug 7, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $22 → $23 | $10.75 | +113.95% | 23 | Aug 6, 2025 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $1.58 | - | 24 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Buy | $15 → $16 | - | - | 19 | Jul 31, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $5 → $4 | $0.83 | +379.90% | 7 | Jul 29, 2025 | |
| CLSD Clearside Biomedical | Downgrades: Neutral | $5 | $0.43 | +1,052.07% | 22 | Jul 18, 2025 | |
| ANGO AngioDynamics | Reiterates: Buy | $16 | $8.84 | +81.00% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $72.30 | +38.31% | 20 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.97 | +169.36% | 3 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $2.17 | +130.41% | 1 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $2.66 | +238.35% | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $12.48 | +20.24% | 27 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.82 | +204.88% | 21 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.13 | +97.15% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $7.44 | +61.29% | 22 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.27 | +214.96% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $53 | $27.47 | +92.94% | 4 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $12.46 | +100.64% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.96 | +136.29% | 13 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $21.43 | +133.32% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.25 | +176.92% | 18 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $12.35 | +215.79% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $18.09 | +76.89% | 14 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.63 | +298.60% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.08 | +224.68% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.32 | +127.27% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.72 | +341.18% | 4 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.77 | +292.16% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.25 | +294.17% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.50 | +300.00% | 16 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.04 | +130.26% | 19 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.22 | +145.90% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $8.10 | +319.75% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.17 | +846.37% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.47 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,250 → $1,125 | $4.06 | +27,609.36% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.23 | +4,164.39% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.35 | +3,007.34% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.67 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $13.05 | +267.82% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $50.06 | -62.05% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.17 | - | 2 | Apr 16, 2020 |
Harrow
Aug 13, 2025
Maintains: Buy
Price Target: $60 → $64
Current: $34.83
Upside: +83.75%
Sensus Healthcare
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.27
Upside: +144.65%
BioLife Solutions
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $32
Current: $24.02
Upside: +33.22%
LifeMD
Aug 7, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $6.83
Upside: +90.34%
EyePoint Pharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $10.75
Upside: +113.95%
Zynex
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.58
Upside: -
Bausch + Lomb
Jul 31, 2025
Maintains: Buy
Price Target: $15 → $16
Current: -
Upside: -
Lexaria Bioscience
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.83
Upside: +379.90%
Clearside Biomedical
Jul 18, 2025
Downgrades: Neutral
Price Target: $5
Current: $0.43
Upside: +1,052.07%
AngioDynamics
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $8.84
Upside: +81.00%
Jul 3, 2025
Reiterates: Buy
Price Target: $100
Current: $72.30
Upside: +38.31%
Jun 27, 2025
Reiterates: Buy
Price Target: $8
Current: $2.97
Upside: +169.36%
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.17
Upside: +130.41%
Jun 18, 2025
Assumes: Buy
Price Target: $9
Current: $2.66
Upside: +238.35%
May 29, 2025
Reiterates: Buy
Price Target: $15
Current: $12.48
Upside: +20.24%
May 29, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.82
Upside: +204.88%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $9.13
Upside: +97.15%
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $7.44
Upside: +61.29%
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.27
Upside: +214.96%
May 15, 2025
Maintains: Buy
Price Target: $51 → $53
Current: $27.47
Upside: +92.94%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $12.46
Upside: +100.64%
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $2.96
Upside: +136.29%
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $21.43
Upside: +133.32%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.25
Upside: +176.92%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $12.35
Upside: +215.79%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $18.09
Upside: +76.89%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.63
Upside: +298.60%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.08
Upside: +224.68%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.32
Upside: +127.27%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.72
Upside: +341.18%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.77
Upside: +292.16%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.25
Upside: +294.17%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $2.50
Upside: +300.00%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $3.04
Upside: +130.26%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $8.10
Upside: +319.75%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $3.17
Upside: +846.37%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.47
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $5,250 → $1,125
Current: $4.06
Upside: +27,609.36%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.23
Upside: +4,164.39%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.35
Upside: +3,007.34%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $13.05
Upside: +267.82%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $50.06
Upside: -62.05%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -